chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm at injection site; This is a spontaneous report from a contactable consumer. An elderly (Age: 71; Units; Unknown) non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration on 26Feb2021 10:45 (Batch/Lot Number: en6198) as unknown, single dose for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included valsartan, amolodipine, rosuvastatin, omeprazole. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 26Feb2021 at 05:00 PM the patient experienced sore arm at injection site. The treatment was not provided for the event. The outcome of the event was recovered. No follow-up attempts are possible. No further information is expected.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Explosive diarrhoea; This is a spontaneous report from a contactable consumer (patient) received via medical information team. A 83-years-old female patient received first dose bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection, Lot Number: EN9581), via an unspecified route of administration, administered in arm left on 08Feb2021 12:30 (at an age of 83-years-old) as 1st dose, single dose for covid-19 immunisation. Medical history included thyroid disorder. Concomitant medication included levothyroxine sodium (SYNTHROID) (MANUFACTURER UNKNOWN), via an unspecified route of administration on an unspecified date at 88 mcg, daily for thyroid mediciene; alendronate sodium (MANUFACTURER UNKNOWN), via an unspecified route of administration on an unspecified date at 88 mcg, daily for bone building. On 23Feb2021, the patient experienced explosive diarrhoea. The female consumer reports receiving her first injection of the Pfizer-BioNTech COVID-19 vaccine on 08Feb2021. Two weeks later, she started experiencing severe diarrhea, which is continuing. She asked if this explosive diarrhea could be a delayed side effect of the vaccine, if this has been reported with the vaccine. she guessed that is the place that she got it where they sent them through like a herd of elephants, unknown if she is going to get the second dose or not relative to these events. The clinical outcome of the explosive diarrhea was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, SARS-CoV-2 test negative
Clinical narrative: This is a spontaneous report from a contactable consumer or other non hcp. A 56-years-old female non pregnant patient received bnt162b2 (BNT162B2(COVID-19 MRNA VACCINE; Solution for injection Batch/Lot Number: EN6202), dose 2 via an unspecified route of administration, administered in Arm Left on 28Feb2021 08:15 as 2nd dose, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient had known allergies. Medical history included seasonal allergy, insomnia. Concomitant medication(s) included cetirizine hydrochloride; ibuprofen cannabidiol (CBD OIL) ergocalciferol (VIT D) taken for an unspecified indication, start and stop date were not reported. Patient previously took first dose of bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration, administered in Arm left on 07Feb202108:15AM Batch/Lot Number was EL9265 as single dose for covid-19 immunisation. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. It was reported that,12 hours post the 2nd vaccine on Feb28 began experiencing fatigue, chills, nausea, headache and skin sensitivity (no rash). It persisted from about 8:30pm on 2/28 until 6pm on 3/1, with symptoms coming and going in severity. On an unspecified date in 2021, the patient was recovered from the events No treatment was received. It was reported that The patient underwent lab tests and procedures which included sars-cov-2 test negative: negative on 25Feb2021 Nasal Swab. No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Sensitive skin
Clinical narrative: This is a spontaneous report from a contactable consumer or other non hcp. A 56-years-old female non pregnant patient received bnt162b2 (BNT162B2(COVID-19 MRNA VACCINE; Solution for injection Batch/Lot Number: EN6202), dose 2 via an unspecified route of administration, administered in Arm Left on 28Feb2021 08:15 as 2nd dose, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient had known allergies. Medical history included seasonal allergy, insomnia. Concomitant medication(s) included cetirizine hydrochloride; ibuprofen cannabidiol (CBD OIL) ergocalciferol (VIT D) taken for an unspecified indication, start and stop date were not reported. Patient previously took first dose of bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration, administered in Arm left on 07Feb202108:15AM Batch/Lot Number was EL9265 as single dose for covid-19 immunisation. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. It was reported that,12 hours post the 2nd vaccine on Feb28 began experiencing fatigue, chills, nausea, headache and skin sensitivity (no rash). It persisted from about 8:30pm on 2/28 until 6pm on 3/1, with symptoms coming and going in severity. On an unspecified date in 2021, the patient was recovered from the events No treatment was received. It was reported that The patient underwent lab tests and procedures which included sars-cov-2 test negative: negative on 25Feb2021 Nasal Swab. No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: nausea; Vomit; This is a spontaneous report from a contactable consumer. A 88-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection), dose 1 via an unspecified route of administration on 27Feb2021 (Lot number: unknown) as single dose for covid-19 immunisation. The patients medical history and concomitant medications were not reported. The patient experienced nausea on 01Mar2021, vomit on 01Mar2021. It was reported that patient mentioned that she was vaccinated on Saturday with the first dose of the COVID vaccine. Everything was fine but yesterday she had been getting nauseated which also brought out some vomit. She would like to know how long is this nausea going to last. The outcome of events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bacterial test positive, Pain, Urine analysis
Clinical narrative: Doctor ran a urine sample and came back showing some bacteria; some pain on her right side; This is a spontaneous report from a contactable consumer. A 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history was not reported. The patient Concomitant medications were not reported. The patient was scheduled for the second dose of Pfizer's COVID vaccine today on 02Mar2021. For the past 5 to 7 days, she had some pain on her right side and went to her family doctor yesterday, 01Mar2021. He ran a urine sample and came back showing some bacteria and gave me an injection of Rocephin and put me on Augmentin. The patient was supposed to go for CAT scan today at 2:30. Caller stated her doctor does not recommend her to receive the vaccine and is asking if it was ok for her to have the vaccine today since she is taking antibiotics? Therapeutic measures were taken and treatment included injection of Rocephin and augmentin for event urine sample and came back showing some bacteria. The relevant lab test included test: urine analysis, results : urine cytology abnormal (bacteria). The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Infection, Pain, Urine analysis
Clinical narrative: Doctor ran a urine sample and came back showing some bacteria; some pain on her right side; This is a spontaneous report from a contactable consumer. A 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history was not reported. The patient Concomitant medications were not reported. The patient was scheduled for the second dose of Pfizer's COVID vaccine today on 02Mar2021. For the past 5 to 7 days, she had some pain on her right side and went to her family doctor yesterday, 01Mar2021. He ran a urine sample and came back showing some bacteria and gave me an injection of Rocephin and put me on Augmentin. The patient was supposed to go for CAT scan today at 2:30. Caller stated her doctor does not recommend her to receive the vaccine and is asking if it was ok for her to have the vaccine today since she is taking antibiotics? Therapeutic measures were taken and treatment included injection of Rocephin and augmentin for event urine sample and came back showing some bacteria. The relevant lab test included test: urine analysis, results : urine cytology abnormal (bacteria). The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: after his first dose he had one day where his blood pressure went "very low"/Low blood pressure; This is a spontaneous report from a contactable consumer (who is the patient, reported for self).  This 84-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EL9262, Expiration date: UNKNOWN), via an unspecified route of administration in the left arm on 23Jan2021 (at the age of 84-year-old) as a single dose for COVID-19 immunisation.   The patient's medical history included high blood pressure and that he was taking pills, it was under control. Patient says occasionally he develops rapid heartbeat, for which he has medication and mainly these are things taking medications for. No further details provided about these medications; Cholesterol and open heart surgery nine years ago and macular degeneration in each eye and puts eyedrops in and occasionally they give him injections. The patient received his second dose on 13Feb2021 (Batch/Lot number: EL9266). Concomitant medications included that he takes Lipitor 10mg every day for his cholesterol. Estrogen 10mg every day for his open-heart surgery. No further details provided about these medications.   The patient initially stated that he has practically had no symptoms with either shot. He said he basically had no symptoms other than after his first shot. The patient then stated that after his first dose he had one day where his blood pressure went "very low" but by the time he talked to his cardiologist it had "gone back to normal" on 25Jan2021 in the morning, that was the only side effect he experienced.  He did not have any other recent vaccinations nor started any new medications. Investigation assessment was not provided. Outcome for the event was resolved on 25Jan2021.  Follow-up (02Mar2021): This is a Follow-up spontaneous report from a contactable consumer. This consumer (patient) reported which included clinical course of events.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Very sore arm for approx. 48 hours; This is a spontaneous report from a contactable consumer (patient). A 55-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiration date was not reported; unable to locate or read the details) via an unspecified route of administration, administered in arm left on 04Feb2021 13:30 as first dose, single for COVID-19 immunization (at the age of 55-year-old). Medical history included known allergies to penicillin from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine sodium (LEVOTHYROXIN) taken for an unspecified indication, start and stop date were not reported (as other medications in two weeks). No other vaccine in four weeks, no covid prior vaccination, no covid tested post vaccination. On unspecified date Feb2021, the patient experienced very sore arm for approximately 48 hours and after 2nd dose, slept for most of day. The patient not received treatment. The outcome for event was resolved on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Joint instability, Oral pain, Pain in extremity
Clinical narrative: Left leg a throbbing pain started wednesday at 1:30 am on the side of the knee down to about 6 inches; When i walked , my knee would almost buckle; right side of mouth throbbing pain , started saturday night had vaccine in the morning.; This is a spontaneous report from a contactable consumer (reported on himself). A 74-Year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: el9265, Expiry date: Unknown) via an unspecified route of administration, in Left arm on 20Feb2021 at 10:00 AM (at the age of 74-years-old), as a single dose for Covid-19 immunization. The patient did not have any medical history. The patient had no known allergies. The patient received medications within 2 weeks of vaccination included SIMVASTATIN, FENOFIBRATE and vitamins (un-specified). Patient did not receive other vaccine in four weeks of vaccination. Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, post vaccination. On 20Feb2021 at 11:00 PM, the patient had experienced right side of mouth throbbing pain, started Saturday night had vaccine in the morning. Left leg a throbbing pain started Wednesday at 1:30 am on the side of the knee down to about 6 inches. When he walked, his knee would almost buckle. He was starting to get better, then on 02Mar2021 (on the day of this report), the side of his mouth started throbbing again. He went to the dentist on 25Feb2021, could not find anything wrong dentally. The event resulted in a Doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The outcome of the events of right side of mouth throbbing pain, started Saturday night had vaccine in the morning, Left leg a throbbing pain started Wednesday at 1:30 am on the side of the knee down to about 6 inches and when he walked, his knee would almost buckle was reported as not recovered.   No follow-up attempts were possible. No further information was expected.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: Stomach pain (burning) a day after the second shot, lasting 4 days so far.; This is a spontaneous report from a contactable consumer reported for himself. A 82-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection Batch/Lot number was not reported) via an unspecified route of administration in Arm Left on 25Feb2021 11:15 as SINGLE DOSE for covid-19 immunization. Medical history and concomitant medication were not reported. Patient had allergies of Keflex. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection Batch/Lot number: unknown) via an unspecified route of administration in Arm Left on 04Feb2021 15:15 as SINGLE DOSE for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. On 27Feb2021 at 20:00 patient experienced stomach pain (burning) a day after the second shot, lasting 4 days so far. Patient didn't received treatment for the event. Outcome of the event stomach pain was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain upper, Diarrhoea, Malaise, Nausea
Clinical narrative: diarrhea; vomiting; upset stomach/really upset; felt nauseous; Stomach ache; not feeling well; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received second dose BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date: unknown), via an unspecified route of administration on 27Feb2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Previously, patient received first dose BNT162B2 (Lot number and expiration date: unknown), via an un-specified route of administration on unspecified date as single dose for covid-19 immunisation (first one, went through it was really nice). The patient got the covid Pfizer vaccine dose 2 on 27Feb2021 (Saturday), the first day was okay, on 27Feb2021 night (Saturday; that night) the patient had an upset stomach and felt nauseous. The patient was suffering and didn't know what to do. He called the doctor, but they won't get back to him till 24-48hrs hours. The patient could only eat crackers and ginger ale since 28Feb2021 (Sunday) morning, and on 01Mar2021 (Monday afternoon) diarrhea started, and vomiting started on 01Mar2021 (last night), the patient only vomited one time. His stomach was really upset. The reporter didn't think the patient needed to go to the hospital for this. Since getting the second covid 19 vaccine, he had upset stomach, stomach aches (start date: 2021), and diarrhea. He had only eaten crackers, saltines and ginger ale. The patient did not want to be transferred because he was not feeling well (start date: 2021). The reporter asked how long these symptoms might last, were they normal side effects, what can the patient do, and the patient was wondering if he should see a health care provider about this right now and what he can do. The outcome for all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: diarrhea; vomiting; upset stomach/really upset; felt nauseous; Stomach ache; not feeling well; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received second dose BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date: unknown), via an unspecified route of administration on 27Feb2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Previously, patient received first dose BNT162B2 (Lot number and expiration date: unknown), via an un-specified route of administration on unspecified date as single dose for covid-19 immunisation (first one, went through it was really nice). The patient got the covid Pfizer vaccine dose 2 on 27Feb2021 (Saturday), the first day was okay, on 27Feb2021 night (Saturday; that night) the patient had an upset stomach and felt nauseous. The patient was suffering and didn't know what to do. He called the doctor, but they won't get back to him till 24-48hrs hours. The patient could only eat crackers and ginger ale since 28Feb2021 (Sunday) morning, and on 01Mar2021 (Monday afternoon) diarrhea started, and vomiting started on 01Mar2021 (last night), the patient only vomited one time. His stomach was really upset. The reporter didn't think the patient needed to go to the hospital for this. Since getting the second covid 19 vaccine, he had upset stomach, stomach aches (start date: 2021), and diarrhea. He had only eaten crackers, saltines and ginger ale. The patient did not want to be transferred because he was not feeling well (start date: 2021). The reporter asked how long these symptoms might last, were they normal side effects, what can the patient do, and the patient was wondering if he should see a health care provider about this right now and what he can do. The outcome for all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Tenderness
Clinical narrative: tenderness in her left arm; mild pain in the arm; This is a spontaneous report from a contactable consumer or other non health care professional. A 77-years-old female patient received bnt162b2 (BNT162B2PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6200, Expiration Date: Jun2021), dose 1 via an unspecified route of administration, in Arm Left on 23Feb2021 (at the age of 77-years-old) as 1 ST DOSE, SINGLE (0.3MCG/0.3m) for Covid-19 immunisation. The patient medical history included seasonal allergy. The patient concomitant medications were not reported. It was reported that, the patient received the 1st dose of the vaccine on 23Feb2021 and experienced nothing more than a little tenderness in her left arm where she gets the shot. She stopped taking her daily Claritin for her seasonal allergies to Tree pollen a day before getting the vaccine until now because she has read on an article and hear on the news that it was not recommended to take antihistamines during Covid19 vaccination. She is due for her 2nd shot on 16Mar2021. She had her first dose but having a minor allergy and tenderness on her arm. she stopped taking the generic Claritin, loratadine 10mg a 24hr antihistamine, takes for allergy to tree pollen that is picking up and affects her year-round, has never had a serious reaction to anything. The patient is asking when she can resume her Claritin and it was reported that if taking the Loratadine 10 mg tablet for her preexisting allergy which she last took on a day before she got her first dose of Covid-19 vaccine on 23Feb2021 can affect the efficacy of the vaccine. Patient also said that she felt mild pain in the arm after she got the first dose of the vaccine which according to her is nothing much serious. The outcome of the events was unknown.  Follow-up(02Mar2021): New information received from a contactable consumer. Which includes: The event (she felt mild pain in the arm) was updated and clinical information added.  No follow-up attempt is possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain
Clinical narrative: Sore and tender lymph nodes in left armpit; This is a spontaneous from a contactable consumer (patient). A non-pregnant 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6200), via an unspecified route of administration in left arm, on 22Feb2021 at 09:00 AM (at the age of 51 years), as single dose, for COVID-19 immunization. The patient had no medical history and no known allergies. The patient's concomitant medication included colecalciferol (VITAMIN D). The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. On 01Mar2021 at 02:00 AM, the patient experienced sore and tender lymph nodes in left armpit. No treatment was administered for the adverse event. The patient had not been tested for COVID-19 post vaccination. The patient had not recovered from the event.  No follow up attempts are possible. No further information is expected.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Eye pain, Headache
Clinical narrative: About 4-5 hours after he received his 1st COVID-19 Vaccine dose, he had sharp pains in his head. The pain was mostly behind his eye.; About 4-5 hours after he received his 1st COVID-19 Vaccine dose, he had sharp pains in his head. The pain was mostly behind his eye.; This is a spontaneous report from a contactable consumer or other non hcp. An 83-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and Expiration Date: was not reported), via an unspecified route of administration, administered in right arm on 01Mar2021 08:00 as single dose for COVID-19 immunization. The medical history included cardiac disorder from an unknown date. The patient's concomitant medications were not reported. The patient did not receive any other vaccinations prior within 4 weeks. On 01Mar2021, about 4-5 hours after vaccination the patient experienced sharp pains in his head, the pain was mostly behind his eye; on 03Mar2021, the patient experienced mild headache. The clinical outcome of the events sharp pains in his head was resolving and mild headache was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site pain
Clinical narrative: Intermittent severe pain at injection site and surrounding arm from elbow to shoulder,; Intermittent severe pain at injection site and surrounding arm from elbow to shoulder,; This is a spontaneous report from a contactable consumer (patient). An 88-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EN6200, Expiration Date: not reported), via an unspecified route of administration, administered in right arm on 19Feb2021 at 13:00 (reported as 01:00 PM) (at the age of 88 years old) as second dose, single for COVID-19 immunization in Clinic facility. Medical history included allergy to sulfa drugs and penicillin, both from unknown date. Patient was not pregnant and prior to vaccine the patient was not diagnosed with COVID-19. No other vaccines in 4 weeks prior to the COVID vaccine and has other medications taken in 2 weeks. The patient was previously given the first dose of BNT162B2, (Lot number: EI926) via an unspecified route of administration, administered in right arm on 29Jan2021 at 02:00PM at the age of 87 years old for COVID-19 immunization. On 23Feb2021 at 12:00AM, about three days after injection (as reported), the patient experienced intermittent severe pain at injection site and surrounding arm from elbow to shoulder, continuing to the day of the report. It was eased but not eliminated by heat, muscle rub, and Advil. Since vaccination, the patient has not been tested for COVID-19. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Neck pain, Pain in extremity, Pneumonia
Clinical narrative: Pneumonia; muscles aches; neck pain; shoulder pain; have soreness in my shoulder, in my neck and in my arm; This is a spontaneous report from a contactable consumer or other non hcp. A 68-years-old male patient received bnt162b2, dose 1 via an unspecified route of administration on 08Feb2021 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunization. Medical history included chronic obstructive pulmonary disease, lung cancer, back disorder, from an unknown date and unknown if ongoing. Concomitant medication(s) included formoterol fumarate, glycopyrronium bromide (BEVESPI AEROSPHERE) taken for chronic obstructive pulmonary disease, start and stop date were not reported; salbutamol sulfate (PROAIR HFA) taken for chronic obstructive pulmonary disease, start and stop date were not reported. On an unspecified date patient experienced pneumonia, muscles aches- myalgia, neck pain, shoulder pain- arthralgia, pain in my arm- pain in extremity. The patient underwent lab tests and procedures which included sars-cov-2 antibody test, x-ray with result unknown.  Patient has been taking treatment for back problem with Hydrocodone or Vicodin. The outcome of Pneumonia, myalgia was unknown, Neck pain was recovered and arthralgia, pain in arm was not recovered.  Information about lot/batch no has been requested.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, X-ray
Clinical narrative: Pneumonia; muscles aches; neck pain; shoulder pain; have soreness in my shoulder, in my neck and in my arm; This is a spontaneous report from a contactable consumer or other non hcp. A 68-years-old male patient received bnt162b2, dose 1 via an unspecified route of administration on 08Feb2021 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunization. Medical history included chronic obstructive pulmonary disease, lung cancer, back disorder, from an unknown date and unknown if ongoing. Concomitant medication(s) included formoterol fumarate, glycopyrronium bromide (BEVESPI AEROSPHERE) taken for chronic obstructive pulmonary disease, start and stop date were not reported; salbutamol sulfate (PROAIR HFA) taken for chronic obstructive pulmonary disease, start and stop date were not reported. On an unspecified date patient experienced pneumonia, muscles aches- myalgia, neck pain, shoulder pain- arthralgia, pain in my arm- pain in extremity. The patient underwent lab tests and procedures which included sars-cov-2 antibody test, x-ray with result unknown.  Patient has been taking treatment for back problem with Hydrocodone or Vicodin. The outcome of Pneumonia, myalgia was unknown, Neck pain was recovered and arthralgia, pain in arm was not recovered.  Information about lot/batch no has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Injection site swelling; This is a spontaneous report from a non-contactable consumer. A adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 03Mar2021 as a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. On 04Mar2021, the patient had injection site swelling. The patient did not receive any treatment for the event. The outcome of the event was recovered on an unspecified date in 2021. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested post-vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on stomach & back; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6198; Expiration date was not reported) on the right arm on 03Mar2021 (07:00) as a single dose, with route of administration unspecified, for COVID-19 immunization at the hospital. Medical history included allergies to mold, dust and mites. The patient was not pregnant at the time of vaccination. Concomitant medication(s) included fluticasone propionate, salmeterol xinafoate (ADVAIR), fluticasone propionate (FLONASE), cetirizine hydrochloride (CETIRIZINE D), prednisone and calcium. On 04Mar2021 (05:00), the patient had rash on the stomach and back. The patient did not receive any treatment for the event. The outcome of the event was not recovered. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested since the vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Light fever; Light chills; Fatigue; Body aches; This is a spontaneous report from a contactable consumer (patient). A 55-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6198; Expiration date was not reported) on the left arm on 25Feb2021 (08:00) as a 1st dose, single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 01Mar2021 (09:00), the patient had light fever, light chills, fatigue and body aches. The patient did not receive any treatment for the events. The outcome of the events was not recovered. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested post-vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Fever; headache; chills; This is a spontaneous report from a non-contactable Nurse (also the patient). A 31-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 03Mar2021 13:45 (1:45PM) (Batch/Lot number was not reported) as 1ST DOSE, Single for covid-19 immunisation. The patient is not pregnant at time of vaccination. Medical history included COVID-19 (If Covid prior vaccination: Yes) and Known allergy: Iv contrast, shellfish. No other vaccine in four weeks and no other medications in two weeks. The patient's concomitant medications were not reported. It was reported that the patient experienced Fever, headache, chills on 04Mar2021 at 16:00 (04:00 PM). The outcome of the events was recovering. No treatment was initiated. The patient was not Covid tested post vaccination.  No follow-up attempts are Possible; information about lot/batch number cannot be obtained.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity, Peripheral swelling, Vaccination site pain, Vaccination site swelling
Clinical narrative: pain in his left wrist; arm pain and swelling to left arm; arm pain and swelling to left arm; swollen under side of his arm where he got the vaccine injected; pain in his left wrist, which was the same arm that he received his injection; This is a spontaneous report from a contactable consumer, the patient. A 84-years-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266), via an unspecified route of administration, administered in left arm on 13Feb2021 (at the age of 84-years-old) as a single dose for covid-19 immunization. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL9262), via an unspecified route of administration, administered in left arm on 23Jan2021 (at the age of 84-years-old) as a single dose for covid-19 immunization. Medical history included hypertension, occasionally rapid heart beat, blood cholesterol abnormal, cardiac operation (9 years ago, macular degeneration (in each eye and puts eyedrops in and occasionally they give him injections). Concomitant medication(s) included atorvastatin (LIPITOR [ATORVASTATIN]; 10mg everyday) taken for blood cholesterol abnormal; estradiol (ESTROGEN; 10mg everyday). The patient did not have any other recent vaccinations or started any new medications. The patient reported practically had no symptoms with either shot. After his first dose he had one day where his blood pressure went very low but by the time he talked to his cardiologist it had gone back to normal and was taking pills, it was under control. Yesterday afternoon he experienced pain in his left wrist, which was the same arm that he received his injection, and describes the pain as not too bad. He states that when he uses his wrist in certain positions, the pain "shoots up." This morning on the lower part of his left arm ("not the top where I got the injection") he has "slight pain." He says this morning his upper arm on the underside where he got it on the left side is swollen. He says he would like to know can it be from vaccine, though maybe he could have strained his wrist, it happened yesterday evening, he had wrist pain and swollen under side of his arm where he got the vaccine injected. He says yesterday late afternoon was the first time, it could be something else, it was the same arm this morning he has a little pain to his upper arm that was not on injection side but below, under it. The patient did not received any treatment, it was not serious pain, it was low level pain, when he uses his wrist and turns it, it comes in more prominent. He says it was not pain that bothers him, if it was not related to the vaccine then he most likely strained his arm.  No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Inappropriate schedule of product administration, Injection site pain, Lethargy, Off label use
Clinical narrative: Dose Number:1, Date of start of drug: 23FEB2021/ Dose Number:2, Date of start of drug: 2MAR2021; Dose Number:1, Date of start of drug: 23FEB2021/ Dose Number:2, Date of start of drug: 2MAR2021; Headache; Lethargy; Injection site pain; This is a spontaneous report received from a contactable other hcp. A 41-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration in Arm Left on 02Mar2021 08:30 as single dose for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. Patient had not covid prior vaccination. The patient had no known allergies. The patient was not pregnant at the time of vaccination. Patient received first dose of  bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration in Arm right on 23Feb2021 08:30 as single dose for covid-19 immunization. The patient experienced headache, lethargy, injection site pain on 02Mar2021 11:00. Patient received inappropriate schedule of vaccine on 02Mar2021, which is off label use. No treatment was received for the events. The outcome of the events headache, lethargy, injection site pain recovered, and the other event was unknown.  No follow-up attempts are Possible. Information about lot/batch number can-not be obtained. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain
Clinical narrative: Site soreness; Generalized muscle soreness; This is a spontaneous reporter from a contactable consumer. A 65-year-old male consumer (patient) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6201) via an unspecified route of administration on 04Mar2021 at 01:15 PM (age at vaccination: 65 years ) on left arm at single dose for COVID-19 immunization. The patient's medical history included hypersensitivity(allergies) to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient Concomitant medications were not reported. It was reported that patient received other unspecified vaccine in four weeks but did not receive other medications in two weeks. On 05Mar2021, the patient experienced site soreness and generalized muscle soreness. No treatment was received for the events. The outcome of events was resolving. No follow-up attempts were possible. No further information was expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Eye disorder
Clinical narrative: Bump near the corner of my left eye.; This is a spontaneous report from a contactable consumer. A 62-year-old (non-pregnant) female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered in left arm on 03mar2021 01:45 PM (at the age of 62-year-old) as 1st dose, single for COVID-19 immunisation. The patient medical history includes obesity and concomitant medications were not reported. Patient was not tested prior to vaccination. No known allergies reported. No other vaccines were taken in 4 weeks prior to vaccination and no medication taken in 2 weeks prior to vaccination. On 03mar2021, after 2 hours of vaccination at 16:00, the patient experienced a bump near the corner of his left eye. No treatment was taken by the patient and the reporter assessed all events as non-serious. The outcome of the events was reported as not recovered.  No follow-up attempts possible. No further information expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Conjunctivitis, Eye swelling
Clinical narrative: Swelling right eye; Conjunctivitis; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 73-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported) via an unspecified route of administration in Arm Left on 03Mar2021 12:00 (at the time of 73-years-old) as first dose, single for covid-19 immunization. Medical history includes HBP (Blood pressure high), hypothyroid and depression. The patient did not receive any other vaccines in four weeks. Prior to vaccination, the patient had not Covid. The patient was not tested for COVID since the vaccination. Patient had no known allergies. facility country was US. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), ergocalciferol (VIT D) and melot within 2 weeks of vaccination, all for unspecified indication from an unknown date and unknown if ongoing. On 03mar2021 13:00 patient experienced swelling right eye and conjunctivitis. Treatment received for the events were unknown. Outcome of the events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be requested.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Cough, Pain
Clinical narrative: Experience cough; chills; low grade temp; body aches; joint pain; This is a spontaneous report from a contactable Nurse, the patient. A 66-years-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9265), via an unspecified route of administration, administered on left arm on 24Feb2021 (at the age of 66-years-old) at single dose for covid-19 immunization at Hospital. Medical history included hypertension, arthritis. The patient had no allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications in two weeks included amlodipine besilate (NORVASC); aspirin [acetylsalicylic acid]; calcium; vitamin d3. The patient had no other vaccine within four weeks. On 03Mar2021, the patient experienced cough, chills, low grade temp, body aches and joint pain. Therapeutic measures were taken and treatment included with tylenol 2 - 500mg tabs every 6 hrs. The relevant lab tests included body temperature, result: low grade temp on an unspecified date. The Outcome of the event was resolving.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Experience cough; chills; low grade temp; body aches; joint pain; This is a spontaneous report from a contactable Nurse, the patient. A 66-years-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9265), via an unspecified route of administration, administered on left arm on 24Feb2021 (at the age of 66-years-old) at single dose for covid-19 immunization at Hospital. Medical history included hypertension, arthritis. The patient had no allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications in two weeks included amlodipine besilate (NORVASC); aspirin [acetylsalicylic acid]; calcium; vitamin d3. The patient had no other vaccine within four weeks. On 03Mar2021, the patient experienced cough, chills, low grade temp, body aches and joint pain. Therapeutic measures were taken and treatment included with tylenol 2 - 500mg tabs every 6 hrs. The relevant lab tests included body temperature, result: low grade temp on an unspecified date. The Outcome of the event was resolving.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Glaucoma, Osteoporosis
Clinical narrative: Glaucoma; Osteoporosis; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as Unknown, Single for covid-19 immunization. Patient relevant medical history included allergy to hair dye, Neosporin and she received Prolia (Prolia for Osteoporosis for 4 weeks ago). The patient concomitant medication(s) included metoprolol, 25mg taken for heart rate increased. On an unspecified date, the patient experienced osteoporosis, glaucoma. Therapeutic measures were taken as a result of osteoporosis, glaucoma (she is taking different medications such as Prolia for Osteoporosis (for 4 weeks ago) and Eye drops for her Glaucoma). The outcome of events was unknown.  Information related to batch/Lot no. was requested.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: mild symptoms - like headache and sore arm; mild symptoms - like headache and sore arm; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was EH9899 and expiration date: not reported), dose 1 via an unspecified route of administration on 17Dec2020 as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. There were no any other product that were taken together with vaccine. The patient experienced mild symptoms-like headache and sore arm on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Sensory loss
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 43-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient had dizziness like someone is pushing me off sensation. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.